Pnc Financial Services Group, Inc. Pro Phase Labs, Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$6.2 - $7.87 $3,720 - $4,722	-600 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.13 - $7.89 $3,078 - $4,734	600 New	600 $4,000
Q4 2020 Feb 12, 2021	SELL	$3.9 - $11.25 $99,067 - $285,772	-25,402 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$2.03 - $2.29 $51,566 - $58,170	25,402	25,402 $0

2.98M

13.7K

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $4.81M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.